Funding

Turn ideas into impact

Viewing all 993 opportunities
Filter Options
993 results :
Filter List
Close
Update Filters
1
Type
Amount
Source
Eligibility
Status
View 993 Results
Clear All Filters

Due: May 7, 2026

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-25-063

Due: May 7, 2026

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Type

Grant

Source

Federal

Opp Number

PAR-25-111

Due: May 11, 2026

Collaboration for Innovative Research on Aircraft Structure (CIRAS)

Type

Cooperative Agreement

Source

Federal

Opp Number

FA865021S2205

Due: May 18, 2026

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)

US $1,500,000

Type

Grant

Source

Federal

Opp Number

PAR-24-210

Due: May 25, 2026

Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)

US $250,000

Type

Grant

Source

Federal

Opp Number

PAR-23-240

Due: May 25, 2026

NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)

Type

Cooperative Agreement

Source

Federal

Opp Number

PAR-23-201

Due: May 25, 2026

NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)

Type

Cooperative Agreement

Source

Federal

Opp Number

PAR-23-204

Due: May 25, 2026

NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)

US $200,000

Type

Grant

Source

Federal

Opp Number

PAR-24-281

Due: May 25, 2026

NEI Collaborative Clinical Vision Research: Chair’s Grant (UG1-Clinical Trial Required)

Type

Cooperative Agreement

Source

Federal

Opp Number

PAR-23-209

Submit your funding opportunity.

Do you have a grant, incentive, funding competition, or other funding source to share?

Next up:

Facilities